A phase I dose-finding study of vorinostat (V) combined with capecitabine (X) and cisplatin (P) as first-line therapy in patients with advanced gastric cancer

被引：0
|
作者：
Yoo, Changhoon [1 ]
Ryu, Min-Hee [1 ]
Ryoo, Baek-Yeol [1 ]
Koo, Dong Hoe [1 ]
Park, Inkeun [1 ]
Kang, Yoon-Koo [1 ]
机构：
[1] Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.73
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
73
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A PHASE I DOSE-FINDING STUDY OF VORINOSTAT (V) COMBINED WITH CAPECITABINE (X) AND CISPLATIN (P) AS FIRST-LINE THERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER
    Yoo, C.
    Ryu, M. H.
    Ryoo, B.
    Koo, D. H.
    Park, I.
    Kang, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 234 - 234
  • [2] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, Chul
    Lee, Jae-Lyun
    Choi, Yoon Hee
    Kang, Byung Woog
    Ryu, Min-Hee
    Chang, Heung Moon
    Kim, Tae Won
    Kang, Yoon-Koo
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 306 - 315
  • [3] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Chul Kim
    Jae-Lyun Lee
    Yoon Hee Choi
    Byung Woog Kang
    Min-Hee Ryu
    Heung Moon Chang
    Tae Won Kim
    Yoon-Koo Kang
    Investigational New Drugs, 2012, 30 : 306 - 315
  • [4] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, C.
    Lee, J.
    Choi, Y.
    Kang, B.
    Ryu, M.
    Chang, H.
    Kim, T.
    Kang, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Phase I dose-finding study of sorafenib in combination with capecitabine and cisplatin as a first-line treatment in patients with advanced gastric cancer
    Kim, C.
    Lee, J.
    Choi, Y.
    Kang, B.
    Ryu, M.
    Ryoo, B.
    Chang, H.
    Kim, T.
    Kang, Y.
    EJC SUPPLEMENTS, 2009, 7 (02): : 379 - 379
  • [6] Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
    Changhoon Yoo
    Min-Hee Ryu
    Young-Soon Na
    Baek-Yeol Ryoo
    Chae-Won Lee
    Jeheon Maeng
    Se-Yeon Kim
    Dong Hoe Koo
    Inkeun Park
    Yoon-Koo Kang
    Investigational New Drugs, 2014, 32 : 271 - 278
  • [7] Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer
    Yoo, Changhoon
    Ryu, Min-Hee
    Na, Young-Soon
    Ryoo, Baek-Yeol
    Lee, Chae-Won
    Maeng, Jeheon
    Kim, Se-Yeon
    Koo, Dong Hoe
    Park, Inkeun
    Kang, Yoon-Koo
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (02) : 271 - 278
  • [8] Phase 2 study of vorinostat combined with capecitabine plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (AGC)
    Yoo, C.
    Ryu, M. H.
    Na, Y. S.
    Park, S. R.
    Lee, C. W.
    Ryoo, B. Y.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S430 - S430
  • [9] Phase I study of vorinostat combined with capecitabine plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer: The results of pharmacodynamic analysis
    Yoo, C.
    Ryu, M. H.
    Na, Y. S.
    Ryoo, B. Y.
    Lee, C. W.
    Maeng, J.
    Kim, S. Y.
    Koo, D. H.
    Park, I.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S636 - S636
  • [10] A phase I dose-finding study of everolimus in combination with capecitabine and oxaliplatin (XELOX) as the first-line chemotherapy for patients with advanced gastric cancer
    Park, Inkeun
    Ryu, Min-Hee
    Ryoo, Baek-Yeol
    Kang, Myoung Joo
    Lee, Changsuk
    Park, Young Soo
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345